MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,175,485
Net Income
$888,740
Net Profit Margin
40.85%
EPS
$0.35
Unit: Dollar
Revenue Breakdown
Clinic Revenue
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
2,175,485
2,015,225
1,583,317
1,757,094
Research and development expenses
-
-
-
0
Impairment loss
-
-
-
0
(gain) loss on disposal of fixed assets
-
-
-
0
Cost of services
1,352,665
1,282,247
1,015,886
1,127,749
Cost of goods sold
60,147
5,152
7,642.75*
-
Selling, general, and administrative expenses
1,906,750
2,176,099
815,540
2,128,088
Impairment of intangible assets
-
-
-14,887,803.75*
-
Depreciation and amortization
145,573
142,698
136,424
136,741
Total operating expenses
3,465,135
3,606,196
-12,912,311
3,392,578
Gain from operations
-1,289,650
-1,590,971
14,495,628
-1,635,484
Gain on lease termination
-
-
-
0
Gain on settlement (note 17)
-
-
-
0
Gain (loss) from equity method joint ventures
-7,154
22,168
23,282
12,827
Gain on changes in fair value
-
-
3,662,517*
-
Gain on remeasurement
2,452,032
-
-
-
Gain on debt extinguishment
-172,621
-
216,798.5*
-876,165
Loss on changes in fair value on warrant liability
-
3,790,225
235,965.5*
-
Gain on settlement of liability (note 18)
-
-
232,375*
-
Interest income
139,514
-
-
-
Interest expense
177,227
180,323
623,676
145,803
Total other income (expense)
2,234,544
-3,948,380
3,275,331
-1,009,141
Net income (gain) from continuing operations before income taxes
944,894
-
17,770,959
-2,644,625
Gain on disposal of nti (note 4)
-
-
767,258.5*
0
Loss on discontinued operations of nti (note 4)
-
-
-2,201,847*
0
Provision for income taxes
56,154
-
14,326,355.5
0
Net income (gain) from continuing operations before income taxes
888,740
-5,539,351
3,444,603.5*
-2,644,625
Net income (gain)
888,740
-5,539,351
2,010,015
-2,644,625
Preferred stock dividends and deemed dividends
-
-
1,807,170
-
Net loss attributable to common shareholders
-
-
202,845
-
Basic EPS
0.42
-3.38
1.732
-0.77
Diluted EPS
0.35
-3.38
1.732
-0.77
Basic Average Shares
2,105,595
1,637,859
117,083*
3,447,622
Diluted Average Shares
2,592,025
1,637,859
117,083*
3,447,622
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Gain on
remeasurement
$2,452,032
Interest income
$139,514
Total other income
(expense)
$2,234,544
(1120.31%↑ Y/Y)
Interest expense
$177,227
(-19.92%↓ Y/Y)
Gain on debt
extinguishment
-$172,621
(75.06%↑ Y/Y)
Clinic Revenue
$2,167,785
(18.32%↑ Y/Y)
Product
$7,700
(-75.60%↓ Y/Y)
Gain (loss) from
equity method joint...
-$7,154
(64.07%↑ Y/Y)
Net income (gain)
from continuing...
$944,894
(129.44%↑ Y/Y)
Gain from operations
-$1,289,650
(56.87%↑ Y/Y)
Total revenue
$2,175,485
(16.73%↑ Y/Y)
Net income (gain)
from continuing...
$888,740
(127.69%↑ Y/Y)
Provision for income taxes
$56,154
Total operating
expenses
$3,465,135
(-28.61%↓ Y/Y)
Net income (gain)
$888,740
(116.82%↑ Y/Y)
Selling, general, and
administrative expenses
$1,906,750
(-13.05%↓ Y/Y)
Cost of services
$1,352,665
(23.69%↑ Y/Y)
Depreciation and
amortization
$145,573
(-14.24%↓ Y/Y)
Cost of goods sold
$60,147
Buy us a coffee
INVO Fertility, Inc. (IVF)
INVO Fertility, Inc. (IVF)